Abstract 926: Nitric oxide enhances tumor progression and disease aggressiveness in pancreatic cancer
Jian Wang(Qilu Hospital of Shandong University), S. Perwez Hussain(National Institutes of Health), Nader Hanna(University of Maryland, Baltimore), Jochen Gaedcke(Universitätsmedizin Göttingen), Thomas Ried(National Institutes of Health), Matthias M. Gaida(Johannes Gutenberg University Mainz), Harris G. Yfantis(University of Maryland, Baltimore), Jim Stauffer(National Cancer Institute), Aaron J. Schetter(AstraZeneca (Singapore)), Peijun He(University of Maryland, Baltimore), Shouhui Yang(National Institutes of Health), H. Richard Alexander(Umeå University), Jonathan M. Weiss(Max Planck Institute for Metabolism Research), Dong Hoon Lee(Korea University), Michael Ghadimi(Universitätsmedizin Göttingen)
Cited by 0
Related Papers
MicroRNA Expression Profiles Associated With Prognosis and Therapeutic Outcome in Colon Adenocarcinoma
|JAMA|2008|1.6k
Multiple Cytokines and Acute Inflammation Raise Mouse Leptin Levels: Potential Role in Inflammatory Anorexia
|The Journal of Experimental Medicine|1997|797
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
|The Lancet Oncology|2015|723
Genomic Profiling of MicroRNA and Messenger RNA Reveals Deregulated MicroRNA Expression in Prostate Cancer
|Cancer Research|2008|708
Genome sequence and genetic diversity of the common carp, Cyprinus carpio
|Nature Genetics|2014|677